December 18, 2020 Corporate and Business News

• Invitation to presentation of Essity's Year-end Report for 2020

• Hexagon strengthens capabilities to serve rapidly evolving architecture, engineering, and construction (AEC) ecosystem with the acquisition of OxBlue

• Antengene Announces Approval of IND Application in China for a Phase 3 Clinical Trial of ATG-010 (Selinexor) in Combination with Bortezomib and Dexamethasone (SVd) for the Treatment of rrMM

• Back to Home

• Archive History